Welcome to our dedicated page for Amn Healthcare news (Ticker: AMN), a resource for investors and traders seeking the latest updates and insights on Amn Healthcare stock.
AMN Healthcare Services, Inc. (NYSE: AMN) is a healthcare workforce company that reports regularly on its financial performance, capital structure and workforce platforms. The AMN news stream features earnings releases, strategic announcements and updates on technology and partnership initiatives that affect its Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions segments.
Investors and industry observers can find quarterly results detailing consolidated revenue, segment performance, gross margin, operating income, and non-GAAP metrics such as adjusted EBITDA and adjusted diluted EPS. These releases also discuss trends in travel nurse staffing, allied staffing, locum tenens, interim leadership, language services and vendor management systems revenue, as well as commentary from management on market conditions and workforce demand.
AMN Healthcare’s news also covers corporate finance developments, including senior notes offerings, amendments to its revolving credit facility and related debt redemption activities. These items provide insight into how the company manages its capital structure and financial flexibility.
In addition, AMN issues news about its workforce technology and partnerships, such as the sale of its Smart Square scheduling software to symplr and the related commercial partnership that links AMN’s WorkWise workforce planning, analytics and AI capabilities with external scheduling and operational tools. The company’s Physician Solutions division also publishes reports on physician and advanced practitioner recruiting incentives, including starting salary trends and demand for medical specialties.
By following AMN Healthcare news, readers can track developments in healthcare staffing demand, the evolution of its workforce technology platforms, and the company’s strategic and financial decisions. This news page aggregates these updates in one place for convenient access.
AMN Healthcare has been awarded the Prime Supplier of the Year title by the Western Regional Minority Supplier Development Council for its commitment to partnering with Minority-owned Business Enterprises (MBEs). In 2021, AMN spent $190 million with diverse businesses, emphasizing its dedication to diversity, equity, and inclusion. The company also supports minority-owned businesses through its Vendor Development Program, facilitating MBE Certification for 100 firms, including 50 Black-Owned businesses. This recognition underscores AMN's role in promoting equitable opportunities and improving socio-economic health.
AMN Healthcare (NYSE: AMN) has been recognized as the top healthcare Managed Services Program (MSP) in the HRO Today 2022 Baker’s Dozen Customer Satisfaction Ratings for seven consecutive years. In this year's rankings, AMN placed fifth in Overall Leaders and third in Quality of Service Leaders among all MSPs globally. This accolade is based on client feedback, affirming AMN's role in addressing healthcare talent shortages and enhancing service quality. AMN's MSPs improve efficiency and deliver value across leading health systems, utilizing advanced recruitment strategies.
AMN Healthcare (NYSE: AMN) has announced the acquisition of Connetics USA, a recruitment firm specializing in international nursing and allied health placements. This strategic move aims to enhance AMN's capacity to address the growing shortage of healthcare professionals in the U.S., which is expected to persist for years. The acquisition will utilize Connetics USA's expertise in immigration and licensure processes, expanding AMN’s international pipeline of healthcare talent and allowing better service to clients, including hospitals and long-term care facilities.
AMN Healthcare Services, a leader in healthcare talent solutions, reported Q1 2022 revenue of $1.553 billion, up 75% year-over-year, with net income soaring 107% to $146 million and GAAP diluted EPS at $3.09. Adjusted diluted EPS reached $3.49, a 105% increase. The company placed a record number of healthcare professionals and saw strong demand across all segments. Operating cash flow was robust at $200 million. Share repurchases totaled $228 million during the quarter. Despite operational challenges, AMN remains optimistic about future growth driven by workforce shortages in the healthcare sector.
Summary not available.
AMN Healthcare Services, Inc. (NYSE: AMN) will hold a conference call on May 5, 2022, at 5:00 p.m. ET to discuss its Q1 2022 financial results and provide Q2 2022 outlook. The earnings news release is anticipated after market close at 4:15 p.m. ET. A live webcast will be available on the company's website, and participants can join via telephone. Replay options for the call will begin at 8:00 p.m. ET on the same day, lasting until 11:59 p.m. ET on May 19, 2022.
Summary not available.
AMN Healthcare (NYSE: AMN) announced the upcoming retirement of President and CEO Susan Salka by year-end, following the appointment of her successor. Salka has played a pivotal role in the company's growth, transforming AMN from $706 million in revenue in 2005 to over $4 billion today, while enhancing its enterprise value from $600 million to over $5 billion. The Board is actively seeking her replacement, with Salka committed to a smooth transition during this leadership change. The company continues to emphasize its commitment to diversity, equity, and inclusion.
Summary not available.
AMN Healthcare's Chief Clinical Officer, Cole Edmonson, has been named one of Staffing Industry Analysts’ 2022 Staffing 100, recognizing exceptional leadership during challenging times in staffing, particularly during the COVID-19 pandemic. Dr. Edmonson attributes this honor to the commitment of the entire AMN team towards improving patient care and supporting healthcare professionals' wellbeing. AMN is known for its total talent solutions for healthcare organizations, helping optimize workforce efficiency and improve patient outcomes.